Fusen Pharmaceutical Company Limited (HKG:1652)
Hong Kong · Delayed Price · Currency is HKD 0.9300
+0.0400 (4.49%)
At close: Feb 13, 2026
HKG:1652 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -174.98 | -188.78 | -36.28 | -34.61 | 16.65 | 70.13 |
Depreciation & Amortization | 44.44 | 41.71 | 35.8 | 34.16 | 23.79 | 22.46 |
Loss (Gain) From Sale of Assets | -0 | -0 | 1.12 | 1.67 | 12.04 | 0.18 |
Asset Writedown & Restructuring Costs | - | - | - | - | - | 22.64 |
Loss (Gain) From Sale of Investments | 0.34 | 0.34 | 0.31 | 37.99 | 21.02 | -2.97 |
Loss (Gain) on Equity Investments | 104.1 | 104.1 | 40.62 | 21.02 | 1.97 | -24.25 |
Stock-Based Compensation | 0.81 | 0.81 | 1.45 | 1.15 | - | 17.63 |
Provision & Write-off of Bad Debts | 9.08 | 9.08 | 17.04 | -4.71 | 0.91 | 4.96 |
Other Operating Activities | -2.42 | 15.98 | 6.81 | 15.4 | 1.99 | -1.82 |
Change in Accounts Receivable | 72.42 | 72.42 | 49.86 | -90.56 | 25.97 | -12.31 |
Change in Inventory | 24.64 | 24.64 | -51.07 | 11.2 | -16.43 | -17.01 |
Change in Accounts Payable | -44.08 | -44.08 | 3.93 | 61.5 | -6.47 | 39.69 |
Change in Unearned Revenue | 14.56 | 14.56 | -63.66 | 64.87 | -6 | 12.01 |
Change in Other Net Operating Assets | 82.96 | 82.96 | -26.12 | -8.6 | -27.66 | 21.87 |
Operating Cash Flow | 131.86 | 133.73 | -20.18 | 110.49 | 47.77 | 153.21 |
Operating Cash Flow Growth | 123.13% | - | - | 131.31% | -68.82% | 651.38% |
Capital Expenditures | -22.28 | -60.96 | -66.24 | -23.86 | -110.13 | -58.65 |
Sale of Property, Plant & Equipment | - | - | 0.17 | 0 | 1.63 | 0.08 |
Sale (Purchase) of Intangibles | -14.49 | -15.34 | -22.27 | - | - | - |
Investment in Securities | 8.86 | 10.7 | -3.33 | 16.02 | -175.12 | -12.52 |
Other Investing Activities | -29.86 | -97.83 | -69.81 | -5.29 | 0.65 | 2.89 |
Investing Cash Flow | -57.77 | -163.42 | -161.48 | -13.13 | -282.98 | -68.2 |
Short-Term Debt Issued | - | - | - | 78.9 | 60 | - |
Long-Term Debt Issued | - | 776.09 | 340.98 | 206.25 | 230.33 | 210.87 |
Total Debt Issued | 706.83 | 776.09 | 340.98 | 285.14 | 290.33 | 210.87 |
Short-Term Debt Repaid | - | - | - | -83.9 | -52 | - |
Long-Term Debt Repaid | - | -735.66 | -223.9 | -223.76 | -193.91 | -220 |
Total Debt Repaid | -690.48 | -735.66 | -223.9 | -307.66 | -245.91 | -220 |
Net Debt Issued (Repaid) | 16.35 | 40.43 | 117.07 | -22.52 | 44.42 | -9.13 |
Issuance of Common Stock | 0 | - | - | - | - | - |
Repurchase of Common Stock | - | -6.46 | -15.99 | -10.07 | -7.39 | -94.79 |
Common Dividends Paid | - | - | - | -6.96 | -8.31 | -3.15 |
Other Financing Activities | -17.32 | -17.97 | -12.58 | -12.22 | -8.19 | -9.27 |
Financing Cash Flow | -0.97 | 15.99 | 88.5 | -51.77 | 20.53 | -116.33 |
Foreign Exchange Rate Adjustments | 0.04 | -0.09 | -0.11 | 1.45 | -1.29 | -2.69 |
Net Cash Flow | 73.17 | -13.79 | -93.26 | 47.04 | -215.98 | -34.01 |
Free Cash Flow | 109.58 | 72.77 | -86.42 | 86.63 | -62.37 | 94.56 |
Free Cash Flow Margin | 45.47% | 22.32% | -15.28% | 17.62% | -16.17% | 19.42% |
Free Cash Flow Per Share | 0.15 | 0.10 | -0.12 | 0.12 | -0.08 | 0.12 |
Cash Interest Paid | 17.93 | 17.97 | 12.58 | 12.22 | 8.19 | 8.94 |
Cash Income Tax Paid | - | 0.85 | 11.09 | -3.33 | 9.4 | 17.87 |
Levered Free Cash Flow | 150.11 | 46.15 | -158.98 | 146.28 | -182.17 | 120.44 |
Unlevered Free Cash Flow | 162.54 | 58.73 | -151.11 | 154.02 | -177.02 | 126.34 |
Change in Working Capital | 150.5 | 150.5 | -87.05 | 38.41 | -30.59 | 44.24 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.